Teva Pharmaceutical Industries Ltd. (TEVJF)
32.84
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Teva Pharmaceutical Industries EPS Diluted (Quarterly): 0.372 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 434.00M |
| Revenue (Quarterly) | 4.471B |
| Total Expenses (Quarterly) | 4.038B |
| Enterprise Value | 52.55B |
| Gross Profit Margin (Quarterly) | 51.33% |
| Profit Margin (Quarterly) | 9.71% |
| Earnings Yield | 1.85% |
| Operating Earnings Yield | 9.41% |
| Normalized Earnings Yield | 5.009 |